{"type":"rich","title":"Moderna Coronavirus Vaccine Trial at CU Anschutz Shows 94.5% Efficacy","version":"1.0","provider_name":"Blubrry","provider_url":"https://blubrry.com","author_name":"CU On The Air Podcast","html":"<iframe src=\"https://player.blubrry.com/?media_url=https%253A%252F%252Fmedia.blubrry.com%252Fcuontheair%252Fcontent.blubrry.com%252Fcuontheair%252F2020_11-20_DrCampbell_01.mp3\" title=\"Blubrry Podcast Player\" scrolling=\"no\" width=\"100%\" height=\"230\" frameborder=\"0\"></iframe>","height":"230","description":"UPDATE: Moderna has requested emergency use authorization from the FDA, and the vaccine could be available to high-risk populations as early as the end of December. More than a quarter million people in the United States and some 3,","thumbnail_url":"http://cuontheair.blubrry.net/wp-content/uploads/2019/02/cu-on-the-air-podcast.png"}